14/8/2024
Orphan Designation
AKIGAI is excited that we were granted an Orphan Designation from the EMA for the treatment of CRPS with our 1st generation EGFR inhibitor tablet.
AKIGAI is excited that we were granted an Orphan Designation from the EMA for the treatment of CRPS with our 1st generation EGFR inhibitor tablet.